Ghrelin modulates the fMRI BOLD response of homeostatic and hedonic brain centers regulating energy balance in the rat.
The orexigenic gut-brain peptide, ghrelin and its G-protein coupled receptor, the growth hormone secretagogue receptor 1a (GHS-R1A) are pivotal regulators of hypothalamic feeding centers and reward processing neuronal circuits of the brain. These systems operate in a cooperative manner and receive a wide array of neuronal hormone/transmitter messages and metabolic signals. Functional magnetic resonance imaging was employed in the current study to map BOLD responses to ghrelin in different brain regions with special reference on homeostatic and hedonic regulatory centers of energy balance. Experimental groups involved male, ovariectomized female and ovariectomized estradiol-replaced rats. Putative modulation of ghrelin signaling by endocannabinoids was also studied. Ghrelin-evoked effects were calculated as mean of the BOLD responses 30 minutes after administration. In the male rat, ghrelin evoked a slowly decreasing BOLD response in all studied regions of interest (ROI) within the limbic system. This effect was antagonized by pretreatment with GHS-R1A antagonist JMV2959. The comparison of ghrelin effects in the presence or absence of JMV2959 in individual ROIs revealed significant changes in the prefrontal cortex, nucleus accumbens of the telencephalon, and also within hypothalamic centers like the lateral hypothalamus, ventromedial nucleus, paraventricular nucleus and suprachiasmatic nucleus. In the female rat, the ghrelin effects were almost identical to those observed in males. Ovariectomy and chronic estradiol replacement had no effect on the BOLD response. Inhibition of the endocannabinoid signaling by rimonabant significantly attenuated the response of the nucleus accumbens and septum. In summary, ghrelin can modulate hypothalamic and mesolimbic structures controlling energy balance in both sexes. The endocannabinoid signaling system contributes to the manifestation of ghrelin's BOLD effect in a region specific manner. In females, the estradiol milieu does not influence the BOLD response to ghrelin.
Laboratory of Endocrine Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.
Miklós
M
Sárvári
Preclinical Imaging Center, Gedeon Richter Ltd., Budapest, Hungary.
Pál
P
Kocsis
Preclinical Imaging Center, Gedeon Richter Ltd., Budapest, Hungary.
Levente
L
Deli
Preclinical Imaging Center, Gedeon Richter Ltd., Budapest, Hungary.
Dávid
D
Gajári
Preclinical Imaging Center, Gedeon Richter Ltd., Budapest, Hungary.
Szabolcs
S
Dávid
Preclinical Imaging Center, Gedeon Richter Ltd., Budapest, Hungary.
Zsófia
Z
Pozsgay
Preclinical Imaging Center, Gedeon Richter Ltd., Budapest, Hungary.
Nikolett
N
Hegedűs
Preclinical Imaging Center, Gedeon Richter Ltd., Budapest, Hungary.
Károly
K
Tihanyi
Laboratory of Endocrine Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary; Faculty of Information Technology, Pázmány Péter Catholic University, Budapest, Hungary.
Zsolt
Z
Liposits
D000818:Animals; D001921:Brain / Q000378:metabolism / Q000473:pathology*; D004958:Estradiol / Q000378:metabolism; D005247:Feeding Behavior; D005260:Female; D005786:Gene Expression Regulation; D054439:Ghrelin / Q000378:metabolism*; D006706:Homeostasis; D007031:Hypothalamus / Q000378:metabolism / Q000473:pathology; D008032:Limbic System / Q000502:physiology; D008279:Magnetic Resonance Imaging; D008297:Male; D009714:Nucleus Accumbens / Q000473:pathology; D010286:Paraventricular Hypothalamic Nucleus / Q000473:pathology; D017397:Prefrontal Cortex / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D043884:Receptor, Cannabinoid, CB1 / Q000378:metabolism; D012201:Reward; D015398:Signal Transduction; D013493:Suprachiasmatic Nucleus / Q000473:pathology; D013997:Time Factors
D054439:Ghrelin; D043884:Receptor, Cannabinoid, CB1; D004958:Estradiol